Bedel Financial Consulting, Inc. Sangamo Therapeutics, Inc Transaction History

Bedel Financial Consulting, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.28 - $6.21 $2,394 - $4,533	-730 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$9.23 - $18.18 $738 - $1,454	80 Added 12.31%	730 $11,000
Q2 2020 Jul 14, 2020	SELL	$6.21 - $11.83 $62,100 - $118,300	-10,000 Reduced 93.9%	650 $6,000
Q1 2020 May 06, 2020	BUY	$5.05 - $8.85 $50,500 - $88,500	10,000 Added 1538.46%	10,650 $68,000
Q1 2018 May 03, 2018	BUY	$16.7 - $26.35 $10,855 - $17,127	650 New	650 $12,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.